Seeing Is Believing
Currently out of the existing stock ratings of Anupam Rama, 290 are a BUY (75.13%), 67 are a HOLD (17.36%), 29 are a SELL (7.51%).
Analyst Anupam Rama, currently employed at JPMORGAN, carries an average stock price target met ratio of 40.72% that have a potential upside of 35.75% achieved within 197 days.
Anupam Rama’s has documented 751 price targets and ratings displayed on 58 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on COGT, Cogent Biosciences at 07-Aug-2025.
Analyst best performing recommendations are on VERA (VERA THERAPEUTICS).
The best stock recommendation documented was for VERA (VERA THERAPEUTICS) at 1/22/2024. The price target of $25 was fulfilled within 3 days with a profit of $8.7 (53.37%) receiving and performance score of 177.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$51
$13.94 (37.61%)
$71
18 days ago
(22-Jul-2025)
6/9 (66.67%)
$11.34 (28.59%)
477
Buy
$57
$19.94 (53.80%)
$55
7 months 30 days ago
(10-Dec-2024)
5/6 (83.33%)
$10.98 (23.86%)
84
Buy
$51
$13.94 (37.61%)
9 months 30 days ago
(10-Oct-2024)
1/1 (100%)
$9.18 (21.95%)
27
Hold
$56
$18.94 (51.11%)
$61
10 months 13 days ago
(27-Sep-2024)
10/13 (76.92%)
$10.39 (22.78%)
223
Hold
$46
$8.94 (24.12%)
$30
1 years 1 months 27 days ago
(13-Jun-2024)
4/4 (100%)
$-0.77 (-1.65%)
169
Which stock is Anupam Rama is most bullish on?
Which stock is Anupam Rama is most reserved on?
What Year was the first public recommendation made by Anupam Rama?